Black Rock Inc. Spring Works Therapeutics, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
224Shares Held
67.5MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$222 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$126 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$122 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$116 Million7.16% of portfolio
-
State Street Corp Boston, MA3.09MShares$105 Million0.01% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.12B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...